文献速递肝病

腺苷酸活化蛋白激酶-液泡腺苷三磷酸酶-pH轴:人肝星状细胞促纤维化表型的关键调节因子

The adenosine monophosphate-activated protein kinase-vacuolar adenosine triphosphatase-pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells.
PubMed 文献 · Hepatology · 2018-07-16

研究探讨液泡型H+腺苷三磷酸酶(v-ATPase)在人肝星状细胞(hHSC)活化中的作用及其受腺苷酸活化蛋白激酶(AMPK)特定亚基的调节。发现活化的hHSC中v-ATPase亚基表达增高,抑制v-ATPase或激活AMPK可降低促纤维化基因谱,且v-ATPase活化呈AMPKα1依赖性。结论认为下调v-ATPase可能是抗纤维化策略的潜在靶点。

要点

  • 活化的hHSC中v-ATPase亚基表达较未活化hHSC增高。
  • 抑制v-ATPase可下调促纤维化基因谱并降低增殖和代谢活性。
  • AMPK激活剂减少v-ATPase亚基及促纤维化标志物表达。

核心结论

  • 下调v-ATPase可能成为抗纤维化策略开发的潜在靶点。

研究设计与样本

  • 研究检测了原代人肝星状细胞(hHSC)活化过程中v-ATPase的功能角色及其受特定AMPK亚基的调节。
  • 使用小鼠胚胎成纤维细胞(特异性缺失AMPKα亚基)验证AMPKα1与AMPKα2对v-ATPase表达的差异调节。
  • 在胆管结扎小鼠纤维化肝脏和人肝硬化肝脏中检测v-ATPase表达。

主要发现

  • 体内和体外活化的hHSC中不同v-ATPase亚基表达较未活化hHSC增高。
  • 巴弗洛霉素和KM91104抑制v-ATPase后,HSC促纤维化基因谱下调,伴随溶酶体pH升高、胞内pH降低、AMPK激活、增殖减少和代谢活性降低。
  • 二氟尼柳、A769662和ZLN024激活AMPK后,v-ATPase亚基及促纤维化标志物表达降低。
  • 在AMPKα1缺失的hHSC中,药物激活AMPK未能阻止v-ATPase下调。
  • 胆管结扎小鼠纤维化肝脏和人肝硬化肝脏中v-ATPase表达增高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Liver fibrosis and cirrhosis are characterized by activation of hepatic stellate cells (HSCs), which is associated with higher intracellular pH (pHi). The vacuolar H+ adenosine-triphosphatase (v-ATPase) multisubunit complex is a key regulator of pHi homeostasis. The present work investigated the functional role of v-ATPase in primary human HSC (hHSC) activation and its modulation by specific adenosine monophosphate-activated protein kinase (AMPK) subunits. We demonstrate that the expression of different v-ATPase subunits was increased in in vivo and in vitro activated hHSCs compared to nonactivated hHSCs. Specific inhibition of v-ATPase with bafilomycin and KM91104 induced a down-regulation of the HSC fibrogenic gene profile, which coincided with increased lysosomal pH, decreased pHi, activation of AMPK, reduced proliferation, and lower metabolic activity. Similarly, pharmacological activation of AMPK by treatment with diflunisal, A769662, and ZLN024 reduced the expression of v-ATPase subunits and profibrogenic markers. v-ATPase expression was differently regulated by the AMPK α1 subunit (AMPKα1) and AMPKα2, as demonstrated in mouse embryo fibroblasts specifically deficient for AMPK α subunits. In addition, activation of v-ATPase in hHSCs was shown to be AMPKα1-dependent. Accordingly, pharmacological activation of AMPK in AMPKα1-depleted hHSCs prevented v-ATPase down-regulation. Finally, we showed that v-ATPase expression was increased in fibrotic livers from bile duct-ligated mice and in human cirrhotic livers. CONCLUSION: The down-regulation of v-ATPase might represent a promising target for the development of antifibrotic strategies. (Hepatology 2018).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Marrone G, De Chiara F, Böttcher K, et al. The adenosine monophosphate-activated protein kinase-vacuolar adenosine triphosphatase-pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells. Hepatology. 2018. PMID: 29663481. doi:10.1002/hep.30029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。